By Annette Estes, PhD; Tanya St. John, PhD; Stephen R. Dager,MD
“Despite emerging evidence of cost-effectiveness and long term efficacy, one-third of all children with ASD receive no intensive behavioral intervention. There are no evidence-based pharmaceutical interventions for treating core ASD symptoms, but medication can be used to treat comorbid conditions that emerge later, such as attention-deficit/hyperactivity disorder and anxiety.
“To summarize, timely diagnosis soon after symptom emergence facilitates beginning ASD-specific interventions that prepare these young children for increased participation in educational settings. It also sets the stage for meeting later developmental challenges in what is typically a lifelong condition.”